Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib

SIMPLE SUMMARY: Inhibition of vascular endothelial growth factor receptor (VEGFR) signaling is associated with an increased risk of thromboembolic and bleeding complications in cancer patients and may cause fatal side effects. The multityrosine kinase inhibitor sorafenib represents an important trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Pomej, Katharina, Scheiner, Bernhard, Park, Dabin, Bauer, David, Balcar, Lorenz, Meischl, Tobias, Mandorfer, Mattias, Reiberger, Thomas, Müller, Christian, Trauner, Michael, Pinter, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602103/
https://www.ncbi.nlm.nih.gov/pubmed/33066190
http://dx.doi.org/10.3390/cancers12102961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602103/
https://www.ncbi.nlm.nih.gov/pubmed/33066190
http://dx.doi.org/10.3390/cancers12102961

Ejemplares similares